Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.
The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.
The Why Files on MSN15h
The Genetic Arms Race | How CRISPR and AI Destroy the WorldHow CRISPR and AI Destroy the World Imagine a world where the genetic code is as easy to edit as a simple copy-and-paste.
Today's medical AI systems represent not just a new diagnostic tool, but a new kind of medical reasoning altogether, writes ...
The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.
Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback